During the past decade, Cedars-Sinai Heart Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 7 clinical trials were completed, i.e. on average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cedars-Sinai Heart Institute" #1 sponsor was "Eiger BioPharmaceuticals" with 2 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Actelion" with 1 trials sponsored, "Duke University" with 1 trials sponsored and "United Therapeutics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cedars-Sinai Heart Institute" #1 collaborator was "Clinical Trials in Organ Transplantation" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Rho Federal Systems Division, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Cedars-Sinai Heart Institute" are "Pulmonary Arterial Hypertension" (3 trials), "Cardiac Allograft Vasculopathy" (1 trials), "Heart Failure" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials) and "Heart Transplant" (1 trials). Many other conditions were trialed in "Cedars-Sinai Heart Institute" in a lesser frequency.

Most popular intervention types in "Cedars-Sinai Heart Institute" are "Drug" (7 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ubenimex" (2 trials), "LCZ696" (1 trials), "LCZ696 placebo" (1 trials), "Macitentan" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cedars-Sinai Heart Institute" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Cedars-Sinai Heart Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Cedars-Sinai Heart Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cedars-Sinai Heart Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".